Curative treatment of hepatocellular carcinoma;Traitement curatif du carcinome hépatocellulaire

Revue du Praticien

Volumn 63, Issue 2, 2013, Pages 229-233

  Barraud, Hélène ^a   Bronowicki, Jean Pierre ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CAUSE OF DEATH; CELL DIFFERENTIATION; CHILD PUGH SCORE; HEALTH STATUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; LYMPH VESSEL METASTASIS; PORTAL HYPERTENSION; RADIOFREQUENCY ABLATION; SHORT SURVEY; TREATMENT OUTCOME; TUMOR VOLUME;

ALGORITHMS; CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MEDICAL ONCOLOGY; REMISSION INDUCTION;

EID: 84875029311     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (15)

1. Consensus conference: indications for liver transplantation, January 19 and 20, 2005, Lyon-Palais des congrès. Text of recommandations (long version). Liver Transpl 2006;12:998-1011.
2. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-9. (Pubitemid 26079803)
3. Mazzaferro V, Bhoori S, Spocito C, et al. Milan criteria in liver transplantation for HCC: an evidence-based analysis on 15 years of experience Liver Transpl 2011;17:S44-57.
4. Yao FY, Xiao L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded critena based on preoperative imaging Am J Transplant 2007;2587-96. (Pubitemid 47561609)
5. Decaens T, Roudot-Thoraval F, Bresson-Hadni S, et al. Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol 2006;12:7319-25. (Pubitemid 44911839)
6. Freeman Jr RH, Wiesner RH, Harper A, et al. UNOS/OPTN Liver Disease Severity Score, UNOS/OPTN Liver and Intestine, UNOS/OPTN Pediatric Transplantation Committees. The new liver allocation system; moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851-8.
7. Lang H, Sotiropoulos GC, Dömland M, et al. Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br J Surg 2005;92:198-202. (Pubitemid 40269334)
8. EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2012;56:908-43.
9. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208-36. (Pubitemid 43112690)
10. Cherqui D, Laurent A, Mocellin N, et al. Liver resection for transplantable hepatocellular carcinoma Long-term survival and role of secondary liver transplantation. Ann Surg 2009;250:738-46.
11. Giovannini M. Le traitement percutané du carcinome hépato-cellulaire: quelle technique choisir? Gastroenterol Clin Biol 2007;31:347-53. (Pubitemid 46555724)
12. Camma C, Di Marco V, Orlando A, et al. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation: a prospective study. J Hepatol 2005;42:535-40. (Pubitemid 40342933)
13. Cho YK, Kim JK, Kim WT, et al. Systematic review of randomized trials for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 2009;49:453-9.
14. Livraghi T, Meloni F, Di Stasi M, et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatotogy 2008;47:82-9. (Pubitemid 351171044)
15. Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequerrcy ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010;252:903-12.